S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:LTHM

Livent (LTHM) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$16.51
$16.51
50-Day Range
$13.04
$18.55
52-Week Range
$12.76
$29.17
Volume
N/A
Average Volume
29.53 million shs
Market Capitalization
$2.97 billion
P/E Ratio
9.22
Dividend Yield
N/A
Price Target
$23.19

Livent MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
40.4% Upside
$23.19 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-13.76%
From $1.89 to $1.63 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.21 out of 5 stars

Basic Materials Sector

114th out of 174 stocks

Chemicals & Allied Products Industry

13th out of 16 stocks

LTHM stock logo

About Livent Stock (NYSE:LTHM)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was founded in 1940 and is headquartered in Philadelphia, Pennsylvania.

LTHM Stock News Headlines

LTHM Apr 2024 19.000 put
LTHM Apr 2024 29.000 call
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
LTHM Apr 2024 21.000 put
LTHM Apr 2024 20.000 call
LTHM Apr 2024 23.000 put
Luna Lithium Ltd. Appoints New Director
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Livent and Other Lithium Stocks Decline Wednesday
What's Up With Livent Stock?
Peeling Back The Layers: Exploring Livent Through Analyst Insights
Livent: Undervalued With Significant Upside Potential
See More Headlines
Receive LTHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livent and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/31/2023
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
1,350
Year Founded
2018

Price Target and Rating

Average Stock Price Target
$23.19
High Stock Price Target
$33.50
Low Stock Price Target
$15.00
Potential Upside/Downside
+40.4%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$273.50 million
Pretax Margin
46.56%

Debt

Sales & Book Value

Annual Sales
$813.20 million
Cash Flow
$1.73 per share
Book Value
$8.04 per share

Miscellaneous

Free Float
177,626,000
Market Cap
$2.97 billion
Optionable
Not Optionable
Beta
1.76

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives


LTHM Stock Analysis - Frequently Asked Questions

Should I buy or sell Livent stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Livent in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LTHM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LTHM, but not buy additional shares or sell existing shares.
View LTHM analyst ratings
or view top-rated stocks.

What is Livent's stock price target for 2024?

8 brokerages have issued 12 month target prices for Livent's stock. Their LTHM share price targets range from $15.00 to $33.50. On average, they expect the company's share price to reach $23.19 in the next year. This suggests a possible upside of 40.4% from the stock's current price.
View analysts price targets for LTHM
or view top-rated stocks among Wall Street analysts.

How were Livent's earnings last quarter?

Livent Co. (NYSE:LTHM) announced its earnings results on Tuesday, October, 31st. The company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.46 by $0.02. The company earned $211.40 million during the quarter, compared to analyst estimates of $264.41 million. Livent had a trailing twelve-month return on equity of 25.60% and a net margin of 40.77%. Livent's revenue was down 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.41 earnings per share.

What other stocks do shareholders of Livent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livent investors own include Albemarle (ALB), AT&T (T), Walt Disney (DIS), NIO (NIO), NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), Pfizer (PFE), Tesla (TSLA) and Alibaba Group (BABA).

When did Livent IPO?

Livent (LTHM) raised $380 million in an initial public offering on Thursday, October 11th 2018. The company issued 20,000,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sach and Credit Suisse served as the underwriters for the IPO and Citigroup, Loop Capital Markets and Nomura were co-managers.

Does Livent have any subsidiaries?
The following companies are subsidiares of Livent: Livent Corporation, Livent Lithium (Zhangjiagang) Co. Ltd., Livent Lithium LLC, Livent USA Corp., and Minera del Altiplano S.A..
Read More
This page (NYSE:LTHM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners